ABSTRACT Five 7-day trials using 336, 24, 24, 40, and 40 Large White male turkeys when 7, 11, 15, 27, and 32 weeks of age, respectively, were conducted to determine the toxic effects of salinomycin. Salinomycin became more toxic as the age of the turkeys increased. When 7-week-old turkeys were fed diets containing 44 or 66 ppm salinomycin, only 1 of 84 died; when turkeys 27 or 32 weeks of age were fed those amounts, 13 of 20 died. Salinomycin at 22 ppm tended to depress rate of growth at young ages and to prevent or decrease growth and to increase mortality at older ages. Caution should be exercised to avoid salinomycin contamination of turkey diets.
INTRODUCTION
A report was received in the fall of 1984 from an integrated turkey and broiler chicken company that several hundred male turkeys approaching market weight had died suddenly (within 24 hr). The cause of mortality was later traced and attributed to the accidental incorporation of salinomycin, a coccidiostat designed for chickens, at a suspected concentration of about 20 ppm in the diet.
Salinomycin has been reported to be toxic to adult turkeys in commercial flocks. After observing suspected salinomycin toxicity in commercial flocks of turkeys, Halvorson et al. (1982) produced dyspnea and death in adult turkeys by feeding them diets containing 24 to 57 ppm salinomycin. Stuart (1983) also reported, in five breeding flocks of turkeys, excessive mortality apparently caused by feeding diets containing by error between 15 and 30 ppm salinomycin. Evidence for the toxicity of monensin at 200 to 300 ppm in diets for turkeys at 25 or more weeks of age has also been reported by Stuart (1978) .
Little evidence on the degree of toxicity of salinomycin in diets of turkeys exists. Therefore, a series of trials was conducted to determine the effects of salinomycin at varying concentrations in diets of turkeys at various ages on feed consumption, body weight gain, and mortality. Because of the general use of salinomycin as a coccidiostat in commercial broiler diets and the potential danger of contaminating turkey diets, the significance of such research is clear.
MATERIALS AND METHODS
Trial 1. For the first trial, 336 Large White male turkeys averaging 2,337 g in body weight at 7 weeks of age were divided into 48 battery pens each with 7 birds. Within a block consisting of eight pens, the basal diet (Table 1) was randomly assigned to two pens, and the same diet with either 22, 44, or 66 pm added salinomycin from salinomycin sodium or 100, 200, or 300 ppm added monensin from monensin sodium was each randomly assigned to one pen. Assigned diets and water were provided ad libitum to the turkeys for 7 days. Effects of each diet on body weight gain, feed consumption, and mortality were determined.
Trials 2 and 3. For Trial 2, 24 Large White male turkeys averaging 4.89 kg at 11 weeks of age were housed individually in cages and provided the basal diet (Table 1 ) and water ad libitum. Feed consumption for each bird was determined daily for 2 days. Birds, balanced for feed consumption, were assigned to the following treatments for a 7-day trial: 1) basal diet, 2) basal diet plus a gelatin capsule (size 000) containing 20 mg salinomycin administered daily, or 3) basal diet with 66 ppm added salinomycin. The oral dose of 20 mg in Treatment 2 was derived from the expected intake of salinomycin in Treatment 3. Trial 3 was a repeat of Trial 2, except turkeys averaging 7.16 kg at 15 weeks of age were used following a 3-day preliminary period and each capsule contained 25 mg salinomycin. Effects of the treatments on body weight gain, feed consumption, and mortality were determined.
1955
Trials 4 and 5. Large White male turkeys at 32 and 27 weeks of age for Trials 4 and 5, respectively, were randomized into floor pens, 2.8 x 3.6 m, to form, in each trial, four groups of 10 turkeys. Diets contained 0, 5.5, 11, and 22 ppm salinomycin in Trial 4 and 0, 22, 44, and 66 ppm in Trial 5. Diets and water were provided ad libitum for 7 days in each trial to determine the effects of each diet on body weight gain, feed consumption, and mortality.
RESULTS
Trial 1. When diets containing 22 ppm salinomycin were fed to turkeys from 7 to 8 weeks of age, body weight gain and feed efficiency decreased 9 and 8%, respectively (Table  2) . However, with diets containing 44 ppm salinomycin, body weight gain, feed consumption, and feed efficiency decreased 38, 15, and 27%, respectively. When diets contained 66 ppm salinomycin, feed consumption decreased 44% and the turkeys lost 20 g rather than gained 569 g in body weight. Only one turkey (in the 66 ppm salinomycin treatment) died during the 7-day trial.
The addition of 100 ppm monensin to the diet failed to affect these parameters. However, from feeding diets containing 200 ppm monensin, body weight gain, feed consumption, and feed efficiency decreased 13,7, and 7%, respectively, and from 300 ppm the decreases were 24, 13, and 13%, respectively.
Trial 2. For turkeys between 11 and 12 weeks of age given a capsule daily containing 20 mg salinomycin or given a diet containing 66 ppm salinomycin, feed consumption was only about 45% that of turkeys given no salinomycin (Table  3) . In contrast to the body weight gain of .60 kg in turkeys fed the basal diet, surviving turkeys assigned the two salinomycin treatments lost .42 and .92 kg body weight, respectively. Five of the turkeys given capsules containing 20 mg salinomycin per day and 1 of the 8 given feed containing 66 ppm salinomycin died during the 7-day trial. 'Average body weight of turkeys at start of trial was 2,337 g; each diet was fed to 6 pens of males, except the basal diet, which was fed to 12 pens; each pen contained seven turkeys.
2 One death on Day 7.
Trial 3. When turkeys between 15 and 16 weeks of age received salinomycin in capsules (25 mg/day) or in the feed (66 ppm), feed consumptions were only 25 and 53% respectively, of that consumed by turkeys without salinomycin in the diet (Table 4) . Turkeys fed the basal diet gained .68 kg, whereas those receiving the two salinomycin treatments lost .66 and .71 kg body weight, respectively. Six of the 8 turkeys given salinomycin in capsules and 4 of the 8 turkeys given salinomycin in the diet died during the 7-day trial.
Trial 4. Body weight gains and feed consumptions of the turkeys at 32 weeks of age appeared unaffected by the presence of 5.5 and 11 ppm salinomycin in the diet (Table 5) . From feeding 2 Feed consumptions during the 2-day pretrial were 316, 318, and 312 g/bird/day, respectively, for the three treatments.
3 Sacrificed because of severe perosis.
"Deaths on Day 3, 4, 5, 6, and 7. 5 Death on Day 7. 1 Average body weights of the eight male turkeys per treatment at the start of the 7-day trial were 7.27, 7.03, and 7.18 kg, respectively, for the three treatments.
2 Feed consumptions during the 3-day pretrial period were 352, 374, and 370 g/bird/day, respectively, for the three treatments.
3 Deaths on Day 1, 3, 4, 5, 5, and 7. 4 Four deaths on Day 6.
the diet containing 22 ppm salinomycin, feed consumptions decreased about 7% and two of the 10 turkeys died. Trial 5. When diets containing 22, 44, and 66 ppm added salinomycin were fed to turkeys 27 weeks of age, feed consumptions decreased 20, 47, and 58%, respectively, which resulted in loss of body weight (Table 5 ). Of the 10 turkeys per treatment, 1, 6, and 7 died from feeding diets containing 22, 44, and 66 ppm, respectively, during the 7-day trial.
DISCUSSION
Salinomycin became more toxic to turkeys as they increased in age. Of turkeys fed diets containing 44 or 66 ppm salinomycin, only 1 of 84 died from the groups at 7 weeks of age but 13 of 20 turkeys died from the groups at 27 weeks of age. At 22 ppm salinomycin, 3 of 20 turkeys at 27 or 32 weeks of age died, indicating high toxicity of salinomycin at this amount for adult or market age turkeys. Halvorson et al. (1982) also reported high mortality in adult turkeys, but not in growing turkeys, from feeding diets containing similar concentrations of salinomycin. Toxic symptoms were also observed when diets containing 22, 44, or 66 ppm salinomycin were fed to turkeys 7 to 8 weeks of age. At 66 ppm, in comparison to 0 ppm, feed consumption decreased 44% and turkeys failed to grow; at the 44 ppm, feed consumption decreased 15% and body weight gain decreased 38%; and at the 22 ppm, body weight gain decreased 9%, an amount approaching significance. These data illustrate the toxic effects of salinomycin in diets of young turkeys.
Monensin, another extensively used commercial ionophore, at 200 or 300 ppm in the diet was also toxic for turkeys between 7 and 8 weeks of age, as indicated by respective decreases of 7 and 13% in feed consumption and 13 and 24% in body weight gain. These data support those of Stuart (1978) who reported mortality from feeding a diet containing 200 ppm monensin to adult turkeys. Results of this study illustrate the toxic effects of salinomycin at various concentrations in diets of turkeys at various ages. Caution must be exercised to avoid feeding turkeys diets contaminated directly with salinomycin or indirectly with broiler diets containing salinomycin.
